Jason Jones

Jason Jones is the Global VP, Clinical Affairs at SoniVie Ltd, leading the development and implementation of clinical studies on the company's renal denervation platform for hypertension treatment. Prior to this, Jason held various leadership roles in clinical and regulatory affairs at companies like InnovHeart S.r.l., Newronika S.p.A., and Stimwave. With a background in exercise physiology and research methodology, Jason has extensive experience in managing global clinical programs in the medical device industry.